Phase II Clinical Trial of Patients With High-Grade Glioma Treated With Intra-Arterial Carboplatin-Based Chemotherapy, Randomized to Treatment With or Without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant Against Severe Thrombocytopenia

Trial Profile

Phase II Clinical Trial of Patients With High-Grade Glioma Treated With Intra-Arterial Carboplatin-Based Chemotherapy, Randomized to Treatment With or Without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant Against Severe Thrombocytopenia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Sodium thiosulfate (Primary) ; Carboplatin; Cyclophosphamide; Etoposide
  • Indications Glioma; Thrombocytopenia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 Jun 2017 Planned End Date changed from 1 Apr 2019 to 30 Apr 2021.
    • 19 Jun 2017 Planned primary completion date changed from 1 Apr 2018 to 30 Apr 2020.
    • 25 May 2016 Planned End Date changed from 1 Dec 2017 to 1 Apr 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top